z-logo
open-access-imgOpen Access
Late renal allograft failure secondary to thrombotic microangiopathy-human immunodeficiency virus nephropathy.
Author(s) -
G. J. Frem,
Helmut G. Rennke,
Mohamed H. Sayegh
Publication year - 1994
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.v491643
Subject(s) - thrombotic microangiopathy , medicine , zidovudine , nephropathy , nephrotic syndrome , renal function , microangiopathy , gastroenterology , immunology , viral disease , human immunodeficiency virus (hiv) , diabetes mellitus , disease , endocrinology
The case of a renal transplant recipient with a known history of iv drug abuse but unknown human immunodeficiency virus (HIV) status who presents after having a stable renal allograft function for 4 yr, with acute/subacute advanced renal failure, nephrotic syndrome, and hypertension, as well as clinical and histologic findings of thrombotic microangiopathy, is reported. He was subsequently found to have a positive serology for HIV-1 with a low CD4 count but no clinical manifestations of the acquired immunodeficiency syndrome. He was treated conservatively with zidovudine (AZT). The patient never regained graft function and was ultimately discharged from the hospital on maintenance dialytic therapy. This is, to our knowledge, the first report of thrombotic microangiopathy in an HIV-1-infected patient presenting late in the course as acute/subacute renal allograft failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom